The trial, named Tumaini, which means “hope” in Swahili, will assess vaccine candidates designed to protect against the Bundibugyo virus, for which no vaccine has been approved
This source provides a summary via RSS.
Continue reading the complete report from the original publisher.
Read Full Story
